APA

Provencio M., Franco F., Gómez-Codina J., Quero Blanco C., Llanos M., Garcia-Arroyo F., de la Cruz L., Gumá J., Delgado J. R., Álvarez R., Chacón J. I., Royuela A. & Rueda A. (20200430). Consolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years. : Leukemia & lymphoma.

Chicago

Provencio Mariano, Franco Fernando, Gómez-Codina José, Quero Blanco Cristina, Llanos Marta, Garcia-Arroyo Francisco, de la Cruz Luis, Gumá Josep, Delgado Juan Ramón, Álvarez Ruth, Chacón José Ignacio, Royuela Ana and Rueda Antonio. 20200430. Consolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years. : Leukemia & lymphoma.

Harvard

Provencio M., Franco F., Gómez-Codina J., Quero Blanco C., Llanos M., Garcia-Arroyo F., de la Cruz L., Gumá J., Delgado J. R., Álvarez R., Chacón J. I., Royuela A. and Rueda A. (20200430). Consolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years. : Leukemia & lymphoma.

MLA

Provencio Mariano, Franco Fernando, Gómez-Codina José, Quero Blanco Cristina, Llanos Marta, Garcia-Arroyo Francisco, de la Cruz Luis, Gumá Josep, Delgado Juan Ramón, Álvarez Ruth, Chacón José Ignacio, Royuela Ana and Rueda Antonio. Consolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years. : Leukemia & lymphoma. 20200430.